Evidence map›Paper›PMID 37519512›Full record

ArticleCureus2023

Quality Improvement Initiative in a Community Hospital to Reduce Central Line Device Utilization Rate.

Esraa Hassan, Bijoy Mathew, Jessica Poehler, Kimberly Kopischke, Greta Zoesch, Noura Attallah, Abbas B Jama, Nitesh K Jain, Eric O Gomez Urena, Syed Anjum Khan

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Esraa HassanCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Bijoy MathewStrategy Consulting Services, Mayo Clinic, Rochester, USA.
Jessica PoehlerCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Kimberly KopischkeCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Greta ZoeschCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Noura AttallahCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Abbas B JamaCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Nitesh K JainCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Eric O Gomez UrenaCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Syed Anjum KhanCritical Care Medicine, Mayo Clinic Health System, Mankato, USA.
Mayo Clinic Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The intensive care unit (ICU) in a community hospital in southwest Minnesota saw a steady increase in central line-associated bloodstream infections (CLABSI) and an increase in the utilization of central lines. The baseline CLABSI rate was 11.36 at the start of the project, which was the highest in the last five years. The corresponding device utilization rate (DUR) was 64%, which increased from a pre-COVID pandemic rate of 45%. Aim The aim of this project was to decrease the ICU DUR by 37.5% from a baseline of 64% to 40% within six months without adversely impacting staff satisfaction. Methods A multidisciplinary team using the define, measure, analyze, improve, and control (DMAIC) methodology reviewed the potential causes of the increased use of central lines in the ICU. The team identified the following major causal themes: process, communication, education, and closed-loop feedback. Once the root causes were determined, suitable countermeasures were identified and implemented to address these barriers. These included reviewing current guidelines, enhanced care team rounding, staff education, and the creation of a vascular access indication algorithm. The team met biweekly to study the current state, determine the future state, evaluate feedback, and guide implementation. Results The pandemic saw a surge in the number of severely ill patients in the ICU, which may have caused an increase in the DUR. The project heightened the awareness of the increased DUR and its impact on the CLABSI rate. The initiation of discussion around this project led to an immediate decline in DUR via increased awareness and focus. As interventions were introduced and implemented, the DUR continued to decrease at a steady rate. Post implementation, the DUR met the project goal of less than 40%. The team continued to track progress and monitor feedback. The DUR continued to meet the goal for three months post implementation. Since the start of the project, there have been no CLABSI events reported. This effort has positively impacted safety and patient outcomes. Conclusions Through a defined process, the central line utilization rate in our ICU was decreased to 37.5% to meet the target goal and has been sustained.

Indexed as

central linecentral line-associated bloodstream infection (clabsi)central line utilizationdevice utilization ratedmaicicuintensive care unitquality improvement

Identifiers

PMID37519512
PMCPMC10373900
OpenAlexW4382241103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.